As of Feb 27
| -0.22 / -5.28%|
The 1 analysts offering 12-month price forecasts for Starpharma Holdings Ltd have a median target of 8.65, with a high estimate of 8.65 and a low estimate of 8.65. The median estimate represents a +118.95% increase from the last price of 3.95.
The current consensus among 2 polled investment analysts is to Buy stock in Starpharma Holdings Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.